Showing results (381-390 of 397) with videos related to

Sort By:
Pageof 40
Chest|February 4, 2021
Ratio of FEV1/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung FunctionSpyridon Fortis, Alejandro P Comellas, Surya P Bhatt, et al.
Chest|June 20, 2014
Prediction of acute respiratory disease in current and former smokers with and without COPDRussell P Bowler, Victor Kim, Elizabeth Regan, et al.
The Journal of Allergy and Clinical Immunology|June 18, 2014
A genome-wide survey of CD4(+) lymphocyte regulatory genetic variants identifies novel asthma genesSunita Sharma, Xiaobo Zhou, Derek M Thibault, et al.
The Journal of Allergy and Clinical Immunology|January 11, 2014
Genome-wide association study and admixture mapping identify different asthma-associated loci in Latinos: the Genes-environments & Admixture in Latino Americans studyJoshua M Galanter, Christopher R Gignoux, Dara G Torgerson, et al.
The Lancet. Infectious Diseases|November 26, 2021
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trialPeter G Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana-Arri, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|April 29, 2025
Pragmatic Evaluation of an Improvement Program for People Living With Modifiable High-Risk COPD Versus Usual Care: Protocols for the Cluster Randomized PREVAIL TrialKatherine Hickman, Yasir Tarabichi, Andrew P Dickens, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 27, 2022
Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?Ana Zabalza, Georgina Arrambide, Susana Otero-Romero, et al.
The Lancet. Respiratory Medicine|July 30, 2016
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trialDonald P Tashkin, Michael D Roth, Philip J Clements, et al.
ERJ Open Research|October 1, 2025
Sex-specific genetic effects on susceptibility to idiopathic pulmonary fibrosisOlivia C Leavy, Anne F Goemans, Tamara Hernandez-Beeftink, et al.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
Genome-wide SNP-sex interaction analysis of susceptibility to idiopathic pulmonary fibrosisOlivia C Leavy, Anne F Goemans, Amy D Stockwell, et al.
Pageof 40